All stocks today
68166 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Sumitomo Dainippon Pharma Co., Ltd. revenue reports

Sumitomo Dainippon Pharma Co., Ltd. financial reports, Sumitomo Dainippon Pharma Co., Ltd. annual revenue in 2019. When does Sumitomo Dainippon Pharma Co., Ltd. report revenue?
Add to widgets
Added to widgets
Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2019 112 396 000 000 $ - 8 658 000 000 $ -
31/12/2018 120 716 000 000 $ - 12 100 000 000 $ -
30/09/2018 110 244 000 000 $ - 12 622 000 000 $ -
30/06/2018 115 911 000 000 $ - 15 247 000 000 $ -
Show:
to

Sumitomo Dainippon Pharma Co., Ltd. financial report charts

Sumitomo Dainippon Pharma Co., Ltd. quarterly report dates

  31/03/2019 31/12/2018 30/09/2018 30/06/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
84 024 000 000 $ 91 128 000 000 $ 83 563 000 000 $ 86 999 000 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
28 372 000 000 $ 29 588 000 000 $ 26 681 000 000 $ 28 912 000 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
112 396 000 000 $ 120 716 000 000 $ 110 244 000 000 $ 115 911 000 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - -
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
11 053 000 000 $ 17 224 000 000 $ 13 793 000 000 $ 15 814 000 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
8 658 000 000 $ 12 100 000 000 $ 12 622 000 000 $ 15 247 000 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
40 395 000 000 $ 20 647 000 000 $ 20 458 000 000 $ 20 864 000 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
101 343 000 000 $ 103 492 000 000 $ 96 451 000 000 $ 100 097 000 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
373 268 000 000 $ 348 157 000 000 $ 348 990 000 000 $ 348 524 000 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
834 717 000 000 $ 830 065 000 000 $ 836 435 000 000 $ 820 240 000 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
137 296 000 000 $ 139 559 000 000 $ 137 585 000 000 $ 138 944 000 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
198 174 000 000 $ 182 805 000 000 $ 191 293 000 000 $ 201 458 000 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
336 579 000 000 $ 332 062 000 000 $ 345 334 000 000 $ 352 426 000 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
40.32 % 40 % 41.29 % 42.97 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
498 138 000 000 $ 498 003 000 000 $ 491 101 000 000 $ 467 814 000 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
29 560 000 000 $ 12 190 000 000 $ 15 453 000 000 $ -8 492 000 000 $

Last revenue report of Sumitomo Dainippon Pharma Co., Ltd. was 31/03/2019. According to last financial report total revenue in Sumitomo Dainippon Pharma Co., Ltd. was 112 396 000 000 US dollar and changed by 0% since last year. Net income in Sumitomo Dainippon Pharma Co., Ltd. was 8 658 000 000 $ in last quartal, net income changes to 0%.

Sumitomo Dainippon Pharma Co., Ltd. stocks data

Sumitomo Dainippon Pharma Co., Ltd. financials